(redirected from Plethora Solutions)
PLEProtein-Losing Enteropathy
PLEPersonal Learning Environment
PLEProduct Line Engineering
PLEPublic Legal Education (Canada)
PLEPlexmar Resources Inc.
PLEPath Length Efficiency
PLEPassword List Editor
PLEPowerline Ethernet
PLEPersonal Learning Edition
PLEPlato Learning Environment
PLEPhotoluminescence Excitation
PLEPortuguês Língua Estrangeira (Portugese)
PLEPolymorphic Light Eruption
PLEPython Learning Environment (software)
PLEPlethora Solutions (UK)
PLEProperty List Editor (software)
PLEProduct Line Executive
PLEPrimary Leaving Examination (Uganda National Examinations Council; education)
PLEPressurised Liquid Extraction
PLEPolypodium Leucotomos Extract
PLEPymatuning Laboratory of Ecology (Pennsylvania)
PLEPersonal Living Expense (taxes)
PLEPrincipal Level Exercise
PLEProgrammable Logic Element
PLEPeak Luminance Enhancement (NEC)
PLEPower Line Engineering PCL (Thailand)
PLEPerinatal Lethality
PLEProgramming Language Exploration
PLEPage Life Expectancy
PLEPhase-Locked Epitaxy
PLEPrimary Longman Express
PLEPaiela Airport (Papua New Guinea)
PLEPrudent Limit of Endurance
PLEPleasant Lea Elementary (Missouri)
PLEProbable Limits of Error
PLEProfessional Learning Exchange
PLEPanel of Legal Experts
PLEPittsburgh and Lake Erie Railroad Company
PLEPlaneringsenhet (Swedish)
PLEParticipatory Learning Exercise
PLEPlanned Limit Endurance
PLEPacketLink Environment
PLEPioneer Living Experience
PLEPapeterie les Entreprises (French: Stationery Enterprises; Canada)
PLEPreliminary Logistic Evaluation
PLEPort Liaison Element (diplomatic clearance requests for Navy ships visiting port.)
References in periodicals archive ?
Companies Mentioned in this Report: Plethora Solutions Holdings Plc, Johnson & Johnson, Ixchelsis Ltd, GlaxoSmithKline Plc, Ampio Pharmaceuticals, Inc.
23 November 2009 - UK-based pharmaceutical and medical devices company Plethora Solutions Holdings plc (LON: PLE) and Columbia Laboratories Inc (NASDAQ: CBRX) announced today that they have executed an exclusive license and distribution agreement whereby Plethora will market Columbia's Striant SR 30 mg mucoadhesive buccal tablets for testosterone replacement therapy in men with hypogonadism in the UK.
In parallel we continue to see the benefits of selecting and supporting capable partners, with the continued growth of OptiFlo and exploitation of our [nanotechnology] through Plethora Solutions.
But the company has, in addition, ended its search for a partner for its micelle propofol - another non-core product that uses polymers to effectively deliver an insoluble anaesthetic -and instead has licensed its micelle nanotechnology delivery system to London-based speciality pharmaceutical company Plethora Solutions Holdings who will use it to develop a treatment for interstitial cystitis and painful bladder syndrome.
We are very excited about these trial results which show that PSD 502 could be the answer for hundreds of thousands of men who suffer the misery of PE," said a spokesman for pharmaceutical development firm Plethora Solutions.
Interims: Datamonitor, Disperse Group, Entertainment Rights, Charles Taylor Consulting, Freeplay Energy, MP Evans, Nautical Petroleum, Personal Group Holdings, Plethora Solutions, PolyFuel, P&MM Group, Sigma Technology, Smallbone, Torex Retail InterimsApace Media, Genemedix (Q2), TripleArc
Plethora Solutions Holdings plc - Product Pipeline Review - 2013
The company has granted a worldwide exclusive licence for its micelle nanotechnology delivery to London-based speciality pharmaceutical company Plethora Solutions Holdings which will use the system for use in treating interstitial cystitis and painful bladder syndrome.
Today Interims: Datamonitor, Disperse, Evans, Freeplay Energy, ICM Computer Group, Nautical Petroleum, P&MM Group, Plethora Solutions, Sigma Technology, Smallbone, Torex Retail
Addex Pharmaceuticals, Evotec Aktiengesellschaft, Plethora Solutions Holdings plc, Melior Discovery, Inc.